white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight
Pay in 4 interest-free payments of $6.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/Featured%20Images%20-%20Fierce%20Healthcare%20-%202025-01-17T060956.289.jpg?VersionId=7lqDaRG_id08agwiginsCp7kjJ9_GaKM)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://i2-prod.irishstar.com/article37207468.ece/ALTERNATES/s1200e/0_Trump-America-250-Memorial-Day-26145640550850.jpg)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://i.abcnewsfe.com/a/95eafab5-efb8-4cc2-98f2-822ab18bd851/wegovy-zepbound-ap-jef-251106_1762445903979_hpMain_16x9.jpg?w=992)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://img.datawrapper.de/ZJY39/full.png)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://endpoints.news/wp-content/uploads/2025/10/GettyImages-2241031598.jpg)

























